---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-033091"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T10:55:30.187186+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tivic Health announces 1-for-17 reverse stock split effective March 7, 2025 to regain Nasdaq compliance

## Summary
- Reverse split at 1:17 ratio; effective 12:01 a.m. ET on March 7, 2025.
- Purpose: regain Nasdaq $1.00 minimum bid price after delisting notice received December 2024.
- Hearing before Nasdaq Panel held Feb 18, 2025; company awaits decision but expects split to aid listing.
- No fractional shares; any fractional interest rounded up to nearest whole share.
- Trading symbol TIVC unchanged; new CUSIP 888705308.

## SEC filing metadata
- accession: 0000950170-25-033091
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017025033091/0000950170-25-033091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017025033091/tivc-20250304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-033091
- JSON: https://secwatch.observer/filing/0000950170-25-033091.json
- Plain text: https://secwatch.observer/filing/0000950170-25-033091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.